Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Area of interest

Area of interest

Technology type

Technology type

Topic selection decision

Topic selection decision

Type

Type

Showing 51 to 75 of 345

Guidance in topic selection
TitleTechnology typeDecisionDecision date
Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]MedicineNot selected
Berotralstat for preventing recurrent attacks of hereditary angioedema in children aged 2 to 12 years [TSID 12132]MedicineNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID 12133_TSID 12135]MedicineNot selected
Clindamycin for treating bacterial vaginosis in females aged 12 and older [TSID 12127]MedicineNot selected
Diclofenac–clotrimazole for Vulvovaginal candidiasis (VVC) [TSID 12053]MedicineNot selected
Lebrikizumab for treating atopic dermatitis in children [TSID12133]MedicineNot selected
Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more treatments (review of TA881) [ID6496]MedicineAwaiting decision
Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy (review of TA673) [ID6403]MedicineAwaiting decision
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]MedicineAwaiting decision
Avatrombopag for treating primary chronic immune thrombocytopenia in people 1 to 17 years [TSID12109]MedicineNot selected
NVK-002 for treating myopia in people 3 to 17 years [TSID11961]MedicineNot selected
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353MedicineNot selected
Transbronchial lung cryobiopsyProcedureAwaiting decision
Noninvasive Vagus Nerve Stimulation For reactive airway diseaseProcedureFurther information required
Selumetinib granules for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children 1 to 6 years [TSID12092]MedicineNot selected
Entrectinib for treating NTRK fusion-positive solid tumours in people 1 month to 11 years [TSID12116]MedicineNot selected
Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]MedicineAwaiting decision
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]MedicineNot selected
Lomitapide for treating homozygous familial hypercholesterolaemia in people 5 to 17 years [TSID 12085]MedicineNot selected
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]MedicineNot selected
Human normal immunoglobulin for preventing infection in chronic lymphocytic leukaemia [TSID12043]MedicineNot selected
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]MedicineNot selected
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]MedicineNot selected
Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]MedicineNot selected
Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic herniaProcedureFurther information required

Results per page

  1. 10
  2. 25
  3. 50
  4. All